tiprankstipranks
Ascentage Pharma Group International Unsponsored ADR (AAPG)
:AAPG
US Market
AAPG
Ascentage Pharma Group International Unsponsored ADR
RESEARCH TOOLSreports

Ascentage Pharma Group International Unsponsored ADR (AAPG) Stock News & Sentiment

Compare
3 Followers
Ascentage Pharma to Announce 2024 Financial Results and Corporate Update
Premium
Company Announcements
Ascentage Pharma to Announce 2024 Financial Results and Corporate Update
1d ago
Ascentage Pharma Group International Unsponsored ADR ( ($AAPG) ) has provided an update. On March 12, 2025, Ascentage Pharma announced it will release its full-year 2024 financial results and provide ...Read more

News Score - Last 7 Days

Neutral
AAPG
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week59%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AAPG’s Media Buzz Sentiment?
1 articles about AAPG were published this week. In an average week, 1 articles are published.
    What is AAPG’s weekly average amount of articles?
    In an average week, 1 articles about AAPG are published.
      What is AAPG’s News Sentiment?
      59% of articles about AAPG were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        PTGXProtagonist Therapeutics
        OPRXOptimizeRx
        CKPTCheckpoint Therapeutics
        CSBTFKuros Biosciences
        FENCFennec Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis